| scholarly article | Q13442814 |
| P50 | author | Rory R. Koenen | Q37829140 |
| Patricia B Maguire | Q58810253 | ||
| Leon Schurgers | Q60061818 | ||
| Birke J Benedikter | Q88208807 | ||
| P2093 | author name string | Johan W M Heemskerk | |
| Frank R Stassen | |||
| Yvonne Henskens | |||
| Martin Parsons | |||
| Alexandra C A Heinzmann | |||
| Tanja Vajen | |||
| Elena M Vasina | |||
| P2860 | cites work | Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation | Q21145728 |
| The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages | Q22253155 | ||
| Fractalkine is expressed by smooth muscle cells in response to IFN-gamma and TNF-alpha and is modulated by metalloproteinase activity | Q24292098 | ||
| FunRich: An open access standalone functional enrichment and interaction network analysis tool | Q24570140 | ||
| Platelets amplify inflammation in arthritis via collagen-dependent microparticle production | Q24627618 | ||
| Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes | Q27317206 | ||
| Single-step isolation of extracellular vesicles by size-exclusion chromatography | Q29395319 | ||
| CD40 ligand promotes Mac-1 expression, leukocyte recruitment, and neointima formation after vascular injury | Q30441065 | ||
| Platelet factor 4: an inhibitor of angiogenesis | Q33361906 | ||
| Shedding of procoagulant microparticles from unstimulated platelets by integrin-mediated destabilization of actin cytoskeleton. | Q33372685 | ||
| Platelets and their chemokines in atherosclerosis-clinical applications | Q34019069 | ||
| Standardization of sample collection, isolation and analysis methods in extracellular vesicle research | Q34369038 | ||
| Arterial smooth muscle cell heterogeneity: implications for atherosclerosis and restenosis development | Q35195495 | ||
| Microparticles from apoptotic platelets promote resident macrophage differentiation. | Q35269888 | ||
| Regulation and characteristics of vascular smooth muscle cell phenotypic diversity. | Q36870887 | ||
| Platelet factor 4 mediates vascular smooth muscle cell injury responses | Q36873325 | ||
| Platelets as cellular effectors of inflammation in vascular diseases | Q37081746 | ||
| miRNA profiling of circulating EpCAM(+) extracellular vesicles: promising biomarkers of colorectal cancer | Q37218300 | ||
| Production of platelet-derived growth factor-like molecules by cultured arterial smooth muscle cells accompanies proliferation after arterial injury | Q37401242 | ||
| Microparticles and vascular dysfunction in obstructive sleep apnoea | Q38195829 | ||
| Smooth muscle cell phenotypic switch: implications for foam cell formation | Q38238775 | ||
| Contribution of platelet CX(3)CR1 to platelet-monocyte complex formation and vascular recruitment during hyperlipidemia | Q39387096 | ||
| Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium | Q40423150 | ||
| Partial inhibition of Cdk1 in G 2 phase overrides the SAC and decouples mitotic events. | Q40465017 | ||
| Aging- and activation-induced platelet microparticles suppress apoptosis in monocytic cells and differentially signal to proinflammatory mediator release | Q40582473 | ||
| Modulation of paracrine signaling by CD9 positive small extracellular vesicles mediates cellular growth of androgen deprived prostate cancer | Q41592660 | ||
| CXC chemokine ligand 4 induces a unique transcriptome in monocyte-derived macrophages | Q41859211 | ||
| Controlled intramyocardial release of engineered chemokines by biodegradable hydrogels as a treatment approach of myocardial infarction | Q42016510 | ||
| Soluble CD40 ligand impairs the function of peripheral blood angiogenic outgrowth cells and increases neointimal formation after arterial injury | Q43202671 | ||
| Tetraspanin CD9 is required for microparticle release from coated-platelets | Q43696479 | ||
| CD40 ligand (CD40L) does not stimulate proliferation of vascular smooth muscle cells | Q43998361 | ||
| Type 1 and type 2 diabetic patients display different patterns of cellular microparticles | Q44114915 | ||
| Thrombin activity and platelet microparticle formation are increased in type 2 diabetic platelets: a potential correlation with caspase activation | Q44247278 | ||
| Platelet microparticles induce angiogenesis in vitro | Q44724662 | ||
| Activated platelets can deliver mRNA regulatory Ago2•microRNA complexes to endothelial cells via microparticles | Q44791838 | ||
| Human vascular smooth muscle cells possess functional CCR5. | Q44837410 | ||
| CD40 ligand+ microparticles from human atherosclerotic plaques stimulate endothelial proliferation and angiogenesis a potential mechanism for intraplaque neovascularization | Q45009308 | ||
| Platelet microparticles enhance the vasoregenerative potential of angiogenic early outgrowth cells after vascular injury | Q46337618 | ||
| Platelet binding to monocytes increases the adhesive properties of monocytes by up-regulating the expression and functionality of beta1 and beta2 integrins | Q46895647 | ||
| The CD40-TRAF6 axis is the key regulator of the CD40/CD40L system in neointima formation and arterial remodeling | Q47245105 | ||
| Heparinase III limits rat arterial smooth muscle cell proliferation in vitro and in vivo | Q47711181 | ||
| The prowess of platelets in immunity and inflammation. | Q50793769 | ||
| Lipid-lowering therapy with statins reduces microparticle shedding from endothelium, platelets and inflammatory cells. | Q50933443 | ||
| Interruption of classic CD40L-CD40 signalling but not of the novel CD40L-Mac-1 interaction limits arterial neointima formation in mice. | Q51746994 | ||
| An engineered CX3CR1 antagonist endowed with anti-inflammatory activity. | Q51778397 | ||
| Vascular smooth muscle cell calcification is mediated by regulated exosome secretion. | Q52964505 | ||
| Platelet CD40 Exacerbates Atherosclerosis by Transcellular Activation of Endothelial Cells and Leukocytes. | Q53192004 | ||
| Platelet microparticles reprogram macrophage gene expression and function. | Q53358769 | ||
| Microvesicles from platelets: novel drivers of vascular inflammation | Q57574568 | ||
| High glucose conditions induce upregulation of fractalkine and monocyte chemotactic protein-1 in human smooth muscle cells | Q57574591 | ||
| Circulating and platelet-derived microparticles in human blood enhance thrombosis on atherosclerotic plaques | Q60651924 | ||
| CD40L stabilizes arterial thrombi by a β3 integrin–dependent mechanism | Q63354517 | ||
| Activated platelets and leucocytes cooperatively stimulate smooth muscle cell proliferation and proto-oncogene expression via release of soluble growth factors | Q73120023 | ||
| Co-localization of CD9 and GPIIb-IIIa (alpha IIb beta 3 integrin) on activated platelet pseudopods and alpha-granule membranes | Q73330680 | ||
| Leukocyte-leukocyte interactions mediated by platelet microparticles under flow | Q73426888 | ||
| Vitronectin receptor (alpha(v)beta3) mediates platelet adhesion to the luminal aspect of endothelial cells: implications for reperfusion in acute myocardial infarction | Q73762713 | ||
| Platelet-derived microparticles stimulate coronary artery smooth muscle cell mitogenesis by a PDGF-independent mechanism | Q73828192 | ||
| Heterogeneity of smooth muscle cell populations cultured from pig coronary artery | Q74461417 | ||
| Platelet microparticles promote platelet interaction with subendothelial matrix in a glycoprotein IIb/IIIa-dependent mechanism | Q77756614 | ||
| Effects of severe hypertension on endothelial and platelet microparticles | Q78945402 | ||
| Atherogenic lipids induce adhesion of human coronary artery smooth muscle cells to macrophages by up-regulating chemokine CX3CL1 on smooth muscle cells in a TNFalpha-NFkappaB-dependent manner | Q80210245 | ||
| Microparticles (ectosomes) shed by stored human platelets downregulate macrophages and modify the development of dendritic cells | Q83985201 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 1 | |
| P921 | main subject | phenotype | Q104053 |
| extracellular vesicle | Q21097485 | ||
| P304 | page(s) | 1322454 | |
| P577 | publication date | 2017-05-16 | |
| P1433 | published in | Journal of extracellular vesicles | Q27724974 |
| P1476 | title | Platelet extracellular vesicles induce a pro-inflammatory smooth muscle cell phenotype | |
| P478 | volume | 6 |
| Q47165109 | A Protocol for Improved Precision and Increased Confidence in Nanoparticle Tracking Analysis Concentration Measurements between 50 and 120 nm in Biological Fluids. |
| Q92890631 | A comparison of methods for the isolation and separation of extracellular vesicles from protein and lipid particles in human serum |
| Q49713070 | Extracellular vesicles in cardiovascular homeostasis and disease. |
| Q52571055 | Initiation and Propagation of Vascular Calcification Is Regulated by a Concert of Platelet- and Smooth Muscle Cell-Derived Extracellular Vesicles. |
| Q94527020 | Microvesicles from indoxyl sulfate-treated endothelial cells induce vascular calcification in vitro |
| Q58738792 | Plasma Membrane Lipid Domains as Platforms for Vesicle Biogenesis and Shedding? |
| Q64235923 | The Bone-Vasculature Axis: Calcium Supplementation and the Role of Vitamin K |
| Q92535745 | The Contrasting Role of Extracellular Vesicles in Vascular Inflammation and Tissue Repair |
| Q64929694 | The effect of mild agonist stimulation on the platelet reactivity in patients with type 2 diabetes mellitus. |
Search more.